ArticleActa clinica Croatica2025
THE ASSOCIATION OF SYNTAX SCORE II WITH LIPID PROFILE, SERUM URIC ACID LEVELS AND DIABETES MELLITUS IN PATIENTS WITH MULTIVESSEL CORONARY DISEASE.
Article in Acta clinica Croatica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The SYNTAX Score II (SS II) is a clinical tool that allows individualized prediction of mortality in patients with multivessel coronary artery disease (CAD) treated with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The aim was to examine whether lipid profile, uric acid and diabetes had a positive correlation with higher values of SS II. The study included 72 CAD patients. An online calculator was used to calculate SS II. Statistical tests (Mann Whitney U test and Shapiro-Wilk test) were used to assess correlations and differences in lipid profile, uric acid and diabetes status according to SS II values. There was a significant positive correlation between the proportion of patients with HDL levels above the reference values and SS II PCI. Patients with lower LDL values had significantly increased values of SS II CABG, but not SS II PCI. There was no significant correlation of total cholesterol and triglycerides with SS II PCI or SS II CABG. Patients with hyperuricemia had significantly higher SS II PCI but not SS II CABG. People with diabetes had significantly increased SS II PCI but not SS II CABG compared to non-diabetic patients. In conclusion, SS II is associated with some of the classic risk factors for atherosclerosis (uric acid, diabetes), whereas in our patient cohort there was a surprising correlation of SS II with high HDL levels and low LDL levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.